Flex Pharma, Inc. (FLKS): Downgrade News

FLKS – Ladenburg Thalmann cuts to neutral. Stock price at the time of this analyst call was $4.18.


Update: As of Jun. 21, 2018, this bearish analyst call has returned -73.21%.


Key Facts Surrounding This News Item


  • FLKS had a POWR Rating of D (Sell) coming into today.
  • FLKS was 5.86% above its 10-Day Moving Average coming into today.
  • FLKS was 7.70% above its 20-Day Moving Average coming into today.
  • FLKS was -6.76% below its 50-Day Moving Average coming into today.
  • FLKS was -10.36% below its 100-Day Moving Average coming into today.
  • FLKS was 1.35% above its 200-Day Moving Average coming into today.
  • FLKS had returned +19.77% year-to-date leading up to today’s news, versus a +4.94% return from the benchmark S&P 500 during the same period.

More Info About Flex Pharma, Inc. (FLKS)


Flex Pharma is a biotechnology company that is developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions. The company was founded in 2014 and is based in Boston, Massachusetts. View our full FLKS ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

FLKS at a Glance

FLKS Current POWR Rating™
Overall POWR Rating™
FLKS Current Price $1.12 1.75%
More FLKS Ratings, Data, and News

FLKS Price Reaction

The day of this event (Jun. 13, 2018)
FLKS Closing Price$1.04 75.12%
FLKS Volume2,811,400
3,541.95% from avg
Leading up to this event
FLKS 1-mo returnN/A%
After this event
FLKS 1-day return209.63%
FLKS 3-day return226.56%
FLKS 5-day return266.67%

FLKS Price Chart



More Flex Pharma, Inc. (FLKS) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All FLKS News
Page generated in 0.7796 seconds.